Regulatory T-cells in systemic lupus erythematosus-associated thrombocytopenia: A comparison with idiopathic thrombocytopenic purpura

Lupus

Volumn 19, Issue 7, 2010, Pages 888-889

  Park, S H ^a   Kim, J Y ^b   Kim, S K ^a   Choe, J Y ^a   Kim, S G ^a   Ryoo, H M ^a  

^a Catholic University of Daegu   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGICAL TOLERANCE; LETTER; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

CASE-CONTROL STUDIES; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES, REGULATORY; THROMBOCYTOPENIA;

EID: 77952903274     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309357062     Document Type: Letter

References (15)

1. Lazarus AH, Ellis J., Semple JW, Mody M., Crow AR, Freedman J. Comparison of platelet immunity in patients with SLE and with ITP. Transfus Sci 2000 ; 22: 19-27.
2. Kuwana M., Kaburaki J., Okazaki Y., Miyazaki H., Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006 ; 45: 851-854.
3. Altintas A., Ozel A., Okur N., et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 2007 ; 24: 163-168.
4. Cines DB, Blanchette VS Immune thrombocytopenic purpura. N Engl J Med 2002 ; 346: 995-1008.
5. Stasi R., Evangelista ML, Stipa E., Buccisano F., Venditti A., Amadori S. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost 2008 ; 99: 4-13.
6. Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 2007 ; 14: 511-514. (Pubitemid 47457642)
7. Lan RY, Ansari AA, Lian ZX, Gershwin ME Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005 ; 4: 351-363.
8. Sakaguchi S., Wing K., Miyara M. Regulatory T cells-a brief history and perspective. Eur J Immunol 2007 ; 37 (Suppl 1). S116-123.
9. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 2008 ; 17: 421-425. (Pubitemid 351798720)
10. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006 ; 27: 110-118.
11. Azab NA, Bassyouni IH, Emad Y., Abd El-Wahab GA, Hamdy G., Mashahit MA CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 2008 ; 127: 151-157.
12. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007 ; 37: 987-996.
13. Kuhn A., Beissert S., Krammer PH CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res 2009 ; 301: 71-81.
14. Cepika AM, Marinic I., Morovic-Vergles J., Soldo-Juresa D., Gagro A. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 2007 ; 16: 374-377.
15. Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 2008 ; 47: 789-794.